Insulet Corporation Announces Pricing of Secondary Public Offering

BEDFORD, Mass., Nov. 7 Insulet Corporation,(Nasdaq: PODD), the manufacturer and marketer of the OmniPod(R) InsulinManagement System, today announced the pricing of its public offering of4,898,398 shares of common stock at $23.25 per share, all of which are beingsold by selling stockholders. Insulet will not receive any proceeds from thesale of shares by the selling stockholders. Insulet has granted to theunderwriters an option to purchase up to 734,759 shares of its common stock atthe public offering price to cover any over-allotments.

A registration statement relating to these securities has been filed withthe Securities and Exchange Commission and has become effective. This pressrelease shall not constitute an offer to sell or the solicitation of an offerto buy, nor shall there be any sale of these securities in any state orjurisdiction in which such offer, solicitation or sale would be unlawful priorto registration or qualification under the securities laws of any such stateor jurisdiction. Any offer or sale will be made only by means of the writtenprospectus forming part of the effective registration statement.

A copy of the prospectus relating to the offering may be obtained bycontacting one of the following:

About Insulet Corporation

Insulet Corporation is an innovative medical device company dedicated toimproving the lives of people with diabetes. The Company's OmniPod InsulinManagement System is a revolutionary, discreet and easy-to-use insulininfusion system that features two easy-to-use parts with no tubing and fully-automated cannula insertion. Through the OmniPod System, Insulet seeks toexpand the use of continuous subcutaneous insulin infusion (CSII) therapyamong people with insulin-dependent diabetes. Founded in 2000, Insulet isbased in Bedford, MA.

Your comments are automatically posted once they are submitted. All comments are however constantly reviewed for spam and irrelevant material (such as product or personal advertisements, email addresses, telephone numbers and website address). Such insertions do not conform to our policy and 'Terms of Use' and are either deleted or edited and republished.Please keep your comments brief and relevant.This section may also have questions seeking help. If you have the information you are welcome to respond, but please ensure that the information so provided is genuine and not misleading.

Disclaimer - All information and content on this site are for information and educational purposes only. The information should not be used for either diagnosis or treatment or both for any health related problem or disease. Always seek the advice of a qualified physician for medical diagnosis and treatment.Full Disclaimer